abstract submission

Click to start abstract submission

Abstract submissions now open

  • Oral Presentation

  • Poster Presentation

submission types

  • Early Stage

    • Screening

    • Diagnosis

    • Prognosis

  • Late Stage

    • Tumor Biology

    • Melanoma Therapy

    • Melanoma Imaging

submission categories

  • Survivorship

  • Acral/Mucosal/Ocular

  • Other areas of Melanoma research/therapy

Submit Abstract here

  • You can submit multiple abstracts, one after the other, through the submission portal

  • Encore and Trials in Progress (TiP) abstracts are acceptable

  • Whilst you can come back to your submission(s) at any time prior to the submission deadline, please ensure you proceed through the entire process to complete your submission. If you fail to do this, your abstract will not be reviewed

  • You can log back into the system and edit your abstract submission at any time until Friday 17 April, 2026

  • An automatic acknowledgement email will be sent once your abstract submission is complete. Please note that the submitting author (if different to the presenting author) will be the one linked to the abstract and will receive all relevant information via email. It is the submitting author’s exclusive responsibility to ensure that all relevant emails are passed onto the presenting author and any other relevant parties.

  • Maximum length is 350 words, 1 image can be included and doesn’t count towards your word limit.

  • Your abstract should contain information on the background/aim, methods, results and conclusions and you are encouraged to use sub-headings.

  • Please copy and paste your abstract and supporting details directly into the portal. Word and PDF documents are NOT supported.

Abstract guidelines

ABSTRACT SUBMISSIONS CLOSE FRIDAY 17 APRIL 2026 at 11:59 PM (AEST).

Please ensure you read the FAQ’s below prior to submitting your abstract. If you have any questions, please contact the Conference Organisers.

  • Online submission portal - Currinda

    Currinda is the registration and abstract submission system in use for AMC 2026.

    If you have not used Currinda before, you will be required to create a new account. You will need to provide the below information to create your account: 

    • Email address 

    • Password 

    • Full name 

    • Organisation 

    • Position 

    • Country 

    • Work phone number 

    • Mobile number 

    The system will not let you proceed until you have completed each of these fields and will prompt you to complete them if they are missed in the initial process. 

    Once you have created an account, you will be able to continue with your submission. 

    You can cut and paste your abstract submission into the text fields. You will be able to:

    • Preview a summary of your submission and make modifications to your satisfaction until submissions close.

    • Indicate your preferred presentation type and category.

    • Add relevant references.

  • You will receive an immediate email notification confirming your submission has been received (please check your junk email if not received shortly after finalising your online submission).

    Once submitted, you will be able to login to make edits to your submission until the submission closing date.

    To do this, please log back in to your online registration dashboard. Click the “manage” button under the Individual Abstract Submission heading. Here you will be able to view, edit or submit a new abstract.

    Note: Once the submission deadline has passed and reviewing has commenced, no changes within the portal are permitted.

  • Once the submission deadline passes, the Program Committee will review all submissions. Once reviews have been completed, notification of programming decisions will come from the ASN Events Team.

  • Final acceptance into the program is conditional upon having a valid AMC 2026 registration.

  • The AMC 2026 proceedings will be published in the online meeting program and app.

    If you do NOT wish to have your abstract published, please select the ‘withhold publishing consent’ option when submitting your abstract.

  • Yes, the AMC 2026 Program Committee will accept encore and TIP (Trials in Progress) abstracts for consideration.